May 2002

|
Volume 2 Issue 5

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
The overwhelming clinical benefit of defibrillation as a treatment for ventricular fibrillation is so obvious that, in the past, any technological design differences among manufacturers and models has perhaps been assumed to be inconsequential. A…
In the past, there have been very few ways from a device-based perspective for physicians to manage pacemaker patients suffering from atrial fibrillation (AF). While the introduction of mode switching into pacemakers was a major improvement, it still…
At the Philadelphia Airport Hilton on Saturday, April 27, 2002, HMP Communications, the publisher of EP Lab Digest, launched the first in a series of four 2002 educational regional electrophysiology meetings. This first EP meeting, by all accounts, w…
Riverside Methodist Hosp-ital, a 1,063-bed, private, not-for-profit hospital is a central Ohio health care leader. In 1999, Riverside ranked fifth in the United States for its number of patient admissions. Riverside remains the Columbus area market l…
The sudden awareness of what could have happened still makes me feel very uncomfortable. The patient that I was about to examine, had just come out of the operating room, still on a respirator, after a successful coronary artery bypass grafting ope…
Electrophysiology (EP) is one of the most rapidly developing fields in medicine today. One of the reasons is the continuing development of advanced products that substantially improve the lives of both clinicians and patients. In the midst of this ra…
Progression of congestive heart failure (CHF), although somewhat slowed by recent therapeutic developments, continues to be a growing problem among men and women age 50-80 years. It afflicts 2-4 million people in the United States and nearly 15 milli…